141 related articles for article (PubMed ID: 36802986)
1. A Rare
Wang C; Yantiss RK; Lieberman MD; Tubito-Massarano F; Qin L; Yemelyanova A; Solomon JP; Hissong E
Int J Surg Pathol; 2023 Sep; 31(6):1139-1145. PubMed ID: 36802986
[TBL] [Abstract][Full Text] [Related]
2. Familial PDGFRA-mutation syndrome: somatic and gastrointestinal phenotype.
Manley PN; Abu-Abed S; Kirsch R; Hawrysh A; Perrier N; Feilotter H; Pollett A; Riddell RH; Hookey L; Walia JS
Hum Pathol; 2018 Jun; 76():52-57. PubMed ID: 29486293
[TBL] [Abstract][Full Text] [Related]
3. PDGFRA-mutant syndrome.
Ricci R; Martini M; Cenci T; Carbone A; Lanza P; Biondi A; Rindi G; Cassano A; Larghi A; Persiani R; Larocca LM
Mod Pathol; 2015 Jul; 28(7):954-64. PubMed ID: 25975287
[TBL] [Abstract][Full Text] [Related]
4. Divergent gastrointestinal stromal tumors in syndromic settings.
Ricci R; Martini M; Cenci T; Riccioni ME; Maria G; Cassano A; Larocca LM
Cancer Genet; 2016; 209(7-8):354-8. PubMed ID: 27318444
[TBL] [Abstract][Full Text] [Related]
5. Telocytes are the physiological counterpart of inflammatory fibroid polyps and PDGFRA-mutant GISTs.
Ricci R; Giustiniani MC; Gessi M; Lanza P; Castri F; Biondi A; Persiani R; Vecchio FM; Risio M
J Cell Mol Med; 2018 Oct; 22(10):4856-4862. PubMed ID: 30117724
[TBL] [Abstract][Full Text] [Related]
6. [Translational research and diagnosis in GIST].
Wardelmann E
Pathologe; 2012 Nov; 33 Suppl 2():273-7. PubMed ID: 22968735
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
[TBL] [Abstract][Full Text] [Related]
8. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z
Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688
[TBL] [Abstract][Full Text] [Related]
9. Malignancies associated with GIST: a retrospective study with molecular analysis of KIT and PDGFRA.
Mayr P; Märkl B; Agaimy A; Kriening B; Dintner S; Schenkirsch G; Schneider-Stock R
Langenbecks Arch Surg; 2019 Aug; 404(5):605-613. PubMed ID: 30877378
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
11. Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.
Farag S; van der Kolk LE; van Boven HH; van Akkooi ACJ; Beets GL; Wilmink JW; Steeghs N
Fam Cancer; 2018 Apr; 17(2):247-253. PubMed ID: 28710566
[TBL] [Abstract][Full Text] [Related]
12. A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del).
Huss S; Künstlinger H; Wardelmann E; Kleine MA; Binot E; Merkelbach-Bruse S; Rüdiger T; Mittler J; Hartmann W; Büttner R; Schildhaus HU
Mod Pathol; 2013 Jul; 26(7):1004-12. PubMed ID: 23599150
[TBL] [Abstract][Full Text] [Related]
13. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
[TBL] [Abstract][Full Text] [Related]
14. Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).
Agaimy A; Otto C; Braun A; Geddert H; Schaefer IM; Haller F
Int J Clin Exp Pathol; 2013; 6(9):1839-46. PubMed ID: 24040448
[TBL] [Abstract][Full Text] [Related]
15. Identifying Secondary Mutations in Chinese Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) by Next Generation Sequencing (NGS).
Du J; Wang S; Wang R; Wang SY; Han Q; Xu HT; Yang P; Liu Y
Pathol Oncol Res; 2020 Jan; 26(1):91-100. PubMed ID: 31758409
[TBL] [Abstract][Full Text] [Related]
16. Hereditary gastrointestinal stromal tumors sharing the KIT Exon 17 germline mutation p.Asp820Tyr develop through different cytogenetic progression pathways.
Veiga I; Silva M; Vieira J; Pinto C; Pinheiro M; Torres L; Soares M; Santos L; Duarte H; Bastos AL; Coutinho C; Dinis J; Lopes C; Teixeira MR
Genes Chromosomes Cancer; 2010 Feb; 49(2):91-8. PubMed ID: 19847891
[TBL] [Abstract][Full Text] [Related]
17. SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors.
Italiano A; Chen CL; Sung YS; Singer S; DeMatteo RP; LaQuaglia MP; Besmer P; Socci N; Antonescu CR
BMC Cancer; 2012 Sep; 12():408. PubMed ID: 22974104
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
Miettinen M; Lasota J
Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
[TBL] [Abstract][Full Text] [Related]
19. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).
Lasota J; Miettinen M
Semin Diagn Pathol; 2006 May; 23(2):91-102. PubMed ID: 17193822
[TBL] [Abstract][Full Text] [Related]
20. [The importance of mutational status in prognosis and therapy of GIST].
Comandone A; Boglione A
Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]